DAC and CLAM are equally effective as early second induction in newly diagnosed AML patients with persistent leukemia in early bone marrow evaluation–a …
K Brzozowski, A Pluta, M Włodarczyk… - Acta Haematologica …, 2024 - journals.viamedica.pl
This study presents a retrospective analysis of patients with acute myeloid leukemia< 60
years of age, who had≥ 10% blasts in early bone marrow evaluation on day 14 of their first …
years of age, who had≥ 10% blasts in early bone marrow evaluation on day 14 of their first …